<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3F1C73AD-36EE-4BD5-9481-5FF0DCFA369E"><gtr:id>3F1C73AD-36EE-4BD5-9481-5FF0DCFA369E</gtr:id><gtr:firstName>Joseph</gtr:firstName><gtr:surname>Okebe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DF45180A-FF55-4FCA-84FB-B2DB24B7A222"><gtr:id>DF45180A-FF55-4FCA-84FB-B2DB24B7A222</gtr:id><gtr:firstName>Umberto</gtr:firstName><gtr:surname>D'Alessandro</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0D30D968-A18F-4A55-B1B2-7937943BDAA7"><gtr:id>0D30D968-A18F-4A55-B1B2-7937943BDAA7</gtr:id><gtr:firstName>Shunmay</gtr:firstName><gtr:surname>Yeung</gtr:surname><gtr:orcidId>0000-0002-0997-0850</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1B14F69F-D4D5-42F0-B730-AF3EED034C16"><gtr:id>1B14F69F-D4D5-42F0-B730-AF3EED034C16</gtr:id><gtr:firstName>Davis</gtr:firstName><gtr:surname>Nwakanma</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8693CE49-3461-4A81-BAE3-8BBF0700D348"><gtr:id>8693CE49-3461-4A81-BAE3-8BBF0700D348</gtr:id><gtr:firstName>Gian Luca</gtr:firstName><gtr:surname>Di Tanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2F9F6FCD-1F32-4351-9ACE-08766F2A1C75"><gtr:id>2F9F6FCD-1F32-4351-9ACE-08766F2A1C75</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Balen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E9EC273D-C3BA-4320-9024-B29F9453264B"><gtr:id>E9EC273D-C3BA-4320-9024-B29F9453264B</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Bradley</gtr:surname><gtr:orcidId>0000-0002-9449-4608</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6181BA02-84BC-4B67-AF7B-8A40B70A0EBA"><gtr:id>6181BA02-84BC-4B67-AF7B-8A40B70A0EBA</gtr:id><gtr:firstName>Juan</gtr:firstName><gtr:surname>Muela Ribera</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CF99A386-990A-49B0-9577-00E756482588"><gtr:id>CF99A386-990A-49B0-9577-00E756482588</gtr:id><gtr:firstName>Koen</gtr:firstName><gtr:surname>Peeters</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9E3F9080-235E-4A26-8C73-002AB6A3500E"><gtr:id>9E3F9080-235E-4A26-8C73-002AB6A3500E</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:surname>Achan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MC_EX_MR%2FN006100%2F1"><gtr:id>63832A5A-3D7C-484F-BB19-FF4A0CA91B83</gtr:id><gtr:title>Reactive household-based self-administered treatment against residual malaria transmission: a cluster randomised trial</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_EX_MR/N006100/1</gtr:grantReference><gtr:abstractText>Treating people carrying malaria parasites irrespective of clinical symptoms has been one of the ways for interrupting transmission. However, such programmes can be challenging and depend on factors such as the risk of being infected but without symptoms and adherence of the communities to treatment. The planned study combines targeted treatment of households of malaria patients; identified as potential malaria carriers, with a strong involvement of existing organizations/structures in the communities and health system. The intervention will be tested through a community-based, clustered randomized trial where malaria patients diagnosed in health facilities will be given sufficient antimalarials to treat all household contacts. The messages that will underpin the intervention will be adapted to the local context through a formative research. At the end of the study, we will measure the effect the intervention on carriage of malaria parasites, the impact on the health system, the incremental cost and cost-effectiveness of the intervention and ahderance rates achieved by the approach.</gtr:abstractText><gtr:technicalSummary>Malaria elimination presents operational and technical challenges that would require adapting existing interventions and health systems. The majority of parasite carriers are asymptomatic and these contribute significantly to maintaining transmission. Incidentally they are difficult to identify and target by existing health systems. The study evaluates a novel approach to decrease and possibly stop residual malaria transmission by combining targeted treatment of potential malaria carriers with a strong community involvement. 
The main research questions are i) whether malaria patients (or their parents for children) can administer a full course of antimalarial treatment provided at health facilities to all individuals living in their households and, ii) if treating all household members of clinical malaria cases reduce and possibly eliminate residual malaria transmission where this is already low? A cluster (village)-randomized trial is planned. In the first year, formative research consisting of a mixed-methods approach, combining qualitative (participant observation, in-depth interviews, case studies and focus group discussions) and quantitative research will be applied to gain an in-depth comprehension of the study setting as well as community- based participatory techniques to improve participation in the intervention and adherence to the treatment. The data generated will be used to adapt the intervention to the local context in order to obtain the best possible adherence and compliance to treatment. The final RHOST will be implemented during the second year of intervention. The primary outcome will be the prevalence of malaria infection (determined by molecular methods) in all age groups at the end of the second intervention year. Other outcomes include the incidence of clinical malaria; prevalence of antimalarial drug resistance molecular markers; impact on the local health system; treatment coverage; and comprehension and acceptability of the intervention, cost and cost-effectiveness analysis. The proposed intervention would be implemented through the health system at the village level, with village health workers supervised by nurses based in health facilities. The results and strategy of the trial may be taken up by other African countries with similar malaria endemicity to drive down transmission. Information on possible approaches to engage communities, the impact(s) upon the local health system and the cost-effectiveness of the intervention will also be provided.</gtr:technicalSummary><gtr:potentialImpactText>We are proposing to evaluate a new approach to deal with the human reservoir of malaria transmission, which would be applicable to many countries with residual malaria transmission. The intervention is based on the strong participation of the communities involved. National Malaria Control Programs as well as international agencies and donors interested in malaria elimination will benefit of the results of this trial as they will be provided with a new way of dealing with residual transmission. In addition, we will provide also information on the intervention's impact on the health local services and on its cost. The intervention is based on the strong participation of the local communities that will increase their ownership on the results obtained. In case of positive results, communities living in malaria endemic areas will benefit of the substantial
reduction or interruption of malaria transmission, which will result in a reduction of the malaria burden.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Reactive Household-based self-administered treatment against residual transmission</gtr:description><gtr:id>F4B540F8-ECE8-4F48-A01C-1D3D786E9171</gtr:id><gtr:impact>None for now</gtr:impact><gtr:partnerContribution>Expertise medical anthropology, health economics, health system research</gtr:partnerContribution><gtr:piContribution>Coordinated the formulation of the project and secured the grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_MR/N006100/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>E4AF608A-CDB6-4CE6-AA10-95B3E043E22F</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>8.1  Organisation and delivery of services</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>237CBF0D-6B87-46FD-A97B-E432D87D3FE6</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>8.2  Health and welfare economics</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>